Rize Oncology Inc. (OTCPK: RZON.F)
Health Care · Pharmaceuticals · CA
$—
— today · — 1Y
Rize Oncology Inc. (OTCPK: RZON.F) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $12.12M.
trading between 0.00 and 0.16.
Tweenvest scores Rize Oncology Inc. across four factors: quality 35/100, value 67/100. Its strongest factor is value.
RZON.F price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.12M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.01
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $0.16
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 75.74M
- Employees
- —
- Next earnings
- —
About Rize Oncology Inc.
GeneTether Therapeutics Inc., a genetic medicines company, focuses on developing gene editing therapies to enhance the efficiency of genome editing technologies. It is developing gene therapies for the treatment of patients with rare and monogenic kidney and skin diseases. The company was founded in 2018 and is based in Kelowna, Canada.
- ISIN
- CA76971M1068
- Founded
- 2018
- Listed since
- Mar 30, 2022
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Godavari Drugs LimitedBSE: 530317 | $12.42M | Rs118.05 | -5.70% |
| Aspire-Lakewood Holdings, Inc.NasdaqCM: ASBP | $12.31M | $8.30 | -5.47% |
| ChoA Pharmaceutical Co., LTD.KOSDAQ: A034940 | $12.21M | ₩2,655.00 | -0.56% |
| IDT Australia LimitedASX: IDT | $12.18M | AU$0.04 | -8.89% |
| Daré Bioscience, Inc.NasdaqCM: DARE | $11.81M | $0.77 | -2.25% |
| AcuCort AB (publ)XSAT: ACUC | $11.70M | Skr0.40 | -19.68% |
| Together Pharma LtdTASE: TGTR | $11.67M | ₪2.08 | +1.07% |
| Argenica Therapeutics LimitedASX: AGN | $11.61M | AU$0.13 | -13.33% |
Figures last refreshed Oct 4, 2026.